Comment on 'Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double-blind, randomised controlled VaSera trial' by Faconti et al.

Guimaraes, Danielle Aparecida; Tanus-Santos, Jose Eduardo

Comment on 'Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double-blind, randomised controlled VaSera trial' by Faconti et al.

Guimaraes, Danielle Aparecida; Tanus-Santos, Jose Eduardo.

Afiliação

Guimaraes DA; Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil.
Tanus-Santos JE; Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil.

Br J Clin Pharmacol ; 85(5): 1035-1036, 2019 05.

Article em En | MEDLINE | ID: mdl-30614030

Assuntos

Diabetes Mellitus Tipo 2; Hipertensão; Anti-Hipertensivos; Método Duplo-Cego; Humanos; Espironolactona

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hipertensão Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google